Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,343.72
(
-0.39%
)
US TECH 100
22,527.60
(
0.88%
)
Dow Jones
45,216.14
(
0.11%
)
Brent Oil
106.14
(
-2.24%
)
Bitcoin
66,537.01
(
-0.25%
)
News Focus
News Focus
Post# of 257314
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122824
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: vinmantoo post# 239071

Thursday, 08/05/2021 10:16:26 PM

Thursday, August 05, 2021 10:16:26 PM

Post# of 257314
ENTA—Addendum to #msg-165295713: Your question came up on today’s CC. Jay Luly re-iterated that ENTA is looking at other (non-protease) MoAs against SARS-CoV-2, but he would not disclose which ones. He thinks monotherapy may be sufficient for acute treatment.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today